CURRICULUM VITAE MARK B. MCCLELLAN, M.D., PH.D. DUKE UNIVERSITY 100 FUQUA DRIVE BOX 90120 DURHAM N.C. 27708 EDUCATION: 1993 Ph.D., Economics, Massachusetts Institute of Technology 1992 M.D., Harvard-MIT Division of Health Science and Technology, cum laude 1991 M.P.A., Regulatory Policy, Kennedy School of Government, Harvard University 1985 B.A., English/Biology, University of Texas, Austin, summa cum laude CLINICAL TRAINING: 1996 Diplomate, American Board of Internal Medicine 1993 – 1995 Resident in Internal Medicine, Department of Medicine, Brigham and Women's Hospital EMPLOYMENT: CURRENT POSTION 2015 - Present Director of the Duke-Margolis Center for Health Policy 2015 - Present Robert J. Margolis MD Professor of Business, Medicine and Health Policy 2015 - Present Faculty Member & Sr. Policy Advisor, University of Texas, Austin, Dell Medical School PREVIOUS POSITIONS 2007 – 2015 Senior Fellow in Economic Studies, Brookings Institution 2013 – 2015 Director, Initiatives on Value and Innovation in Health Care, Brookings Institution 2007 – 2013 Director, Engelberg Center for Health Care Reform, Brookings Institution 2006 – 2007 Visiting Senior Fellow, AEI-Brookings Joint Center for Regulatory Studies, American Enterprise Institute and the Brookings Institution 2004 – 2006 Administrator, Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services 2002 – 2004 Commissioner, U. S. Food and Drug Administration 2001 – 2002 Member, Council of Economic Advisers, and Senior Director for Health Care Policy, White House 2000 – 2007 Associate Professor with tenure, Department of Economics and Department of Medicine, Stanford University (on leave 2001-2007) 1998 – 1999 Deputy Assistant Secretary for Economic Policy, U.S. Department of the Treasury 1998 – 2001 Director, Program on Health Outcomes Research, Stanford Medical School 1995 – 1999 Assistant Professor, Department of Economics and Department of Medicine, Stanford University 1995 – 2001 Attending Physician in Internal Medicine, Stanford Health Services 1991 – 1995 Research Associate, Department of Health Care Policy, Harvard Medical School 1989 – 1991 Consultant, RAND Corporation 1 ADVISORY POSITIONS AND AFFILIATIONS: Board Member, Alignment Healthcare Board Member, Cigna Corporation Board Member, FasterCures Board Member, Institute for Accountable Care Board Member, Johnson & Johnson Board Member, Long-Term Quality Alliance Board Member, National Alliance for Hispanic Health Board Member, PrognomIQ Board Member, Research!America Board Member, West Health Institute Sr. Advisor, Reagan-Udall Foundation Advisory Board Member, Arsenal Healthcare Advisory Board Member, Peterson Center on Healthcare Advisory Board Member, USofCare Advisor, American Well Advisor, Blackstone Life Sciences Advisor, Center for Aging Services Technologies Advisor, CRG Advisor, HealthMine Advisor, Health Tech 4 Medicaid Advisor, MITRE Research Associate, National Bureau of Economic Research (Aging and Health Care Programs) Represented Speaker, Washington Speakers Bureau Executive Committee Chair, Clinical Trials Transformation Initiative Co-Chair, Health Care Payment Learning & Action Network (HCP-LAN) Chair, National Academy of Medicine Consortium for a Value and Science-Driven Health System Member, National Academy of Medicine, National Academy of Sciences Member, National Academy of Social Insurance SELECTED HONORS AND AWARDS: 1985 Phi Beta Kappa 1988 John F. Kennedy Fellowship in Public Policy (Harvard University) 1992 Aesculapian Society (Harvard Medical School) 1994 Review of Economic Studies Award, Outstanding Dissertation in Economics 1994 Finalist, National Academy of Social Insurance Dissertation Prize 1995 Finalist, Best Research Paper, Association for Health Services Research 1996 John M. Olin Faculty Research Fellowship 1997 Kenneth Arrow Award, Best Research Paper in Health Economics 1999 Career Development Award, National Institute on Aging 1999 Griliches Award, Best Empirical Research Paper, Quarterly Journal of Economics/Journal of. Political Economy 2000 National Fellow, Hoover Institution 2001 Kenneth Arrow Award, Best Research Paper in Health Economics 2003 Elected to Institute of Medicine, National Academy of Sciences 2003 VIDA (Vision, Innovation, Dedication, and Advocacy) Award, National Alliance for Hispanic Health 2003 Indispensable Person in Health Research Award, Alliance for Aging Research 2004 Cancer Leadership Award, Friends of Cancer Research 2 2004 King David Award for Public Leadership, Jerusalem Fund 2005 AMA Joseph F. Boyle Award for Distinguished Public Service 2005 Public Service Leadership Award, National Coalition for Cancer Survivorship 2006 Booker T. Washington Award, National Minority Health Month Foundation 2006 The Surgeon General’s Medallion for Outstanding Commitment and Dedication to the Health and Welfare of All People, and Exemplary Service in the Public Trust 2008 The Presidential Citation in Recognition of Contributions to Promoting High Quality Innovative and Affordable Health Care, The American College of Cardiology 2008 The American College of Cardiology Foundation 39th Annual Louis F. Bishop Lecturer, 57th Annual Scientific Session 2008 Star of Texas Healthcare Award 2009 Marshall Seidman Distinguished Lecturer in Health Policy, Harvard Medical School 2011 Cutter Lecture on Preventive Medicine, Harvard School of Public Health 2013 Thomas Ferguson Distinguished Lecturer, American Society of Thoracic Surgeons 2014 Pollock Distinguished Lecture, American Society of Neuroradiology Fogarty Distinguished Lecturer, Stanford University 2015 Visiting Fellow, Hoover Institution 2016 Harvey Wiley Award and Lecture, Distinguished Service for Public Health, Food and Drug Administration Alumni Association and Food and Drug Law Institute 2017 National Association of Health Data Organizations Elliott Stone Award of Excellence in Health Data Leadership PUBLICATIONS: 1. “Appropriateness of Care: A Comparison of Global and Outcome Methods to Set Standards,” Mark B. McClellan, Robert H. Brook. Medical Care. Philadelphia: July, 1992. Vol. 30, Iss. 7; p. 565-586. 2. “Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality? Analysis Using Instrumental Variables,” Mark B. McClellan, Barbara J. McNeil, Joseph P. Newhouse. Journal of the American Medical Association. Chicago: September, 1994. Vol. 272, Iss. 11; p. 859-866. 3. “Uncertainty, Health Care Technologies, and Health Care Choices,” Mark B. McClellan. American Economic Review Papers and Proceedings. Nashville: May, 1995. Vol. 85, Iss. 2; p. 38-44. 4. “The Uncertain Demand for Medical Care: A Comment on Emmett Keeler,” Mark B. McClellan. Journal of Health Economics. Amsterdam: June, 1995. Vol. 14, Iss. 2; p. 239-242. 5. “Do Doctors Practice Defensive Medicine?” Daniel P. Kessler, Mark B. McClellan. Quarterly Journal of Economics. Cambridge: May, 1996. Vol. 111, Iss. 2; p. 353-390. 6. “Are the Returns to Technological Change in Health Care Declining?” Mark McClellan. Proceedings of the National Academy of Sciences of the United States of America. Washington: November, 1996. Vol. 93, Iss. 23; p. 12701-12708. 7. “The Marginal Cost-Effectiveness of Medical Technology: A Panel Instrumental-variables Approach,” Mark B. McClellan, Joseph P. Newhouse. Journal of Econometrics. Amsterdam: March, 1997. Vol. 77, Iss. 1; p. 39-64. 8. “Hospital Reimbursement Incentives: An Empirical Analysis,” Mark B. McClellan. Journal of Economics and Management Strategy. Oxford: Spring, 1997. Vol. 6, Iss. 1; p. 91-128. 3 9. “The Effects of Malpractice Pressure and Liability Reforms on Physicians' Perceptions of Medical Care,” Daniel P. Kessler, Mark B. McClellan. Journal of Law and Contemporary Problems. Durham: Winter, 1997. Vol. 60, Iss. 1-2; p. 81-106. 10. “Econometrics in Outcomes Research: The Use of Instrumental Variables,” Joseph P. Newhouse, Mark B. McClellan. Annual Review of Public Health. Palo Alto: May, 1998. Vol. 19; p. 17-34. 11. “Technological Change in Heart-Disease Treatment: Does High-Tech Mean Low Value?” Mark B. McClellan, Haruko Noguchi. American Economic Review. Nashville: May, 1998. Vol. 88, Iss. 2; p. 90-96. 12. “What Has Increased Medical-Care Spending Bought?” David M. Cutler, Mark B. McClellan, Joseph P. Newhouse. American Economic Review. Nashville: May, 1998. Vol. 88, Iss. 2; p. 132- 136. 13. “Are Medical Prices Declining? Evidence from Heart Attack Treatments,” David M. Cutler, Mark B. McClellan, Joseph P. Newhouse, Dahlia Remler. Quarterly Journal of Economics. Cambridge: November, 1998. Vol. 113, Iss. 4; p. 991-1024. 14. “Risks and Costs of End-Stage Renal Disease After Heart Transplantation,” John Hornberger, Jennie Best, Jeffrey Geppert, Mark B. McClellan. Transplantation. Baltimore: December, 1998. Vol. 66, Iss. 12; p. 1763-1770. 15. “Medicare Reform: Who Pays, and Who Benefits?” Mark B. McClellan, Jonathan S. Skinner. Health Affairs. Bethesda: Jan/Feb, 1999. Vol. 18, Iss. 1; p. 48-62. 16. “A Global Analysis of Technological Change in Health Care: The Case of Heart Attacks: Preliminary report from the TECH research network,” Mark B. McClellan, Daniel P. Kessler on behalf of the TECH Investigators. Health Affairs. Bethesda: May, 1999. Vol. 18, Iss. 3: p. 250- 255 17. “How does managed care do it? Prices and productivity in managed care,” David M. Cutler, Mark B. McClellan, Joseph P. Newhouse. RAND Journal of Economics. Santa Monica: Autumn, 2000. Vol. 31, Iss. 3; p. 526-548. 18. “Designing a Medicare Prescription Drug Benefit: Issues, Obstacles and